TickerGuard
Buy Day today: Neutral (59) Mixed market breadth · major macro event coming up
ONC

BeiGene, Ltd.

Healthcare · Biotechnology

356.00$ -0.8% vs. previous close Closing price · As of: Aug 13, 2026

Statements

Income Statement

BeiGene, Ltd. (ONC) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 5,343 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ONC
Line item 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
11 13 8.8 1.1 238 198 428 309 1,176 1,416 2,459 3,810 5,343
13 22 58 98 274 708 71 71 165 286 380 594 669
-2.3 -8.8 -49 -97 -36 -509 357 238 1,011 1,129 2,079 3,216 4,674
13 22 58 98 269 679 927 1,295 1,459 1,641 1,779 1,953 2,146
3.1 6.9 7.3 20 63 195 600 990 1,279 1,508 1,831 2,081
3.1 6.9 7.3 20 63 196 1,317 1,896 2,450 2,919 3,287 3,784 4,227
-5.5 -16 -57 -117 -98 -706 -960 -1,658 -1,439 -1,790 -1,208 -568 447
3.2 3.6 1.2 0.4 4.1 14 52 4.4 22 58
-7.9 -19 -57 -119 -91 -690 -944 -1,618 -1,439 -1,961 -826 -533 417
3.3 3.9 -2.1 0.1 2.2 -16 7.0 10 19 43 56 112 130
-7.5 -18 -57 -119 -93 -674 -949 -1,625 -1,458 -2,004 -882 -645 287
-3.1 -14 -55 -115 -94 -695 -941 -1,626 -1,392 -1,895 -738 -361 617

Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?